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Introduction
Trapold (1970) found that, in a biconditional discrimination task, subjects 
who were trained with unique and distinct outcomes following each 
discriminative stimulus-response (S-R) sequence acquired the task in 
significantly fewer trials than those subjects for whom only one outcome 
was employed. This training procedure, referred to as differential outcomes 
(DO), is shown in Figure 1, along with the more traditional common 
outcomes (CO) procedure where only one outcome is employed, or a 
nondifferential outcomes (NDO) procedure where two outcomes are 
employed but the outcome presented after each S-R sequence is random. 
Figure 1. Common, differential and nondifferential outcomes. 
This improvement in performance, called the differential outcomes effect 
(DOE) is also seen across delays as an improvement in working memory; 
that is, subjects trained under DO perform with greater accuracy across 
delays, even at delay intervals where subjects trained under CO or NDO are 
performing at near chance levels. This DOE is strong enough to allow 
subjects to overcome the effects of amnestic drugs and lesions designed to 
mimic the effects of Korsakoff’s syndrome (Savage, 2008). The difference 
in performance may be due to the separate procedures engaging different 
forms of memory. To solve a choice task under CO or NDO, subjects must 
remember the discriminative stimulus presented at the beginning of the trial 
using retrospective memory. However, we theorize that subjects under DO 
develop outcome-specific expectancies of the specific outcomes associated 
with each sample and it is these prospective memories of what is to come 
(rather than memory of what has already happened) that guides behavior on 
any given trial (Holden and Overmier, 2015). These retrospective and 
prospective codes may well be mediated by different memory systems in the 
brain, dependent on different classes of neurotransmitters and different areas 
of the brain (e.g. frontal lobes and limbic system). Our laboratory has 
conducted a series of pilot studies examining how a number of drugs linked 
to memory influence behavior under DO and NDO in the hopes of 
establishing neurochemical similarities and differences between the two 
systems. 
Scopolamine is a medication commonly prescribed to treat nausea and 
vomiting by acting as an antagonist to the excitatory neurotransmitter, 
acetylcholine. Ravel, Elaagouby, and Gervais (1998) found that rats who had 
received scopolamine injections into the olfactory bulbs had impaired short-
term memory when completing delayed matching tasks involving odor 
recognition; however this was only after a 30 second interval delay. Ferreira, 
Gervais, Durkin, and Lévy, (1999) found that scopolamine inhibited odor 
retention in ewes (female sheep), which prevented them from recognizing 
their lamb, but only for ewes who had eight hours of contact or less with 
their lamb. Some researchers found that scopolamine reduced the accuracy 
in delayed matching to position tasks in rats, but only when the subjects 
were required to complete the tasks over longer intervals of retention 
(Pontecorvo, Clissold, White & Ferkany, 1991). (Other studies have 
indicated working memory inhibition during non-matching to position tasks 
in rats that received scopolamine (Spencer, Pontecorvo, & Heise, 1985)). 
However, Savage (2008) presents data suggesting that performance under 
NDO is more affected by scopolamine than performance under DO, 
supporting a stronger cholinergic component to retrospective memory than 
prospective memory. Following this, it is hypothesized that scopolamine 
will significantly decrease memory performance in the NDO group, but 
less so in the DO group.
The Delayed Matching to Position (MTP) Task 
Matching-to-Position: Sessions ran for 80 trials. At the beginning of each
trial, the stimulus above either the left or right lever is illuminated and that
lever is extended into the chamber; this is the discriminative stimulus. Two
responses on the illuminated lever have the effects of extinguishing this
light, retracting the lever, and illuminating the light over the back wall
lever. For the trial to progress, the subject must then turn to the back wall
lever and press. (This is done to ensure subjects do not bridge a delay
period by merely remaining in front of the correct lever.) The first response
after a 1-second delay period leads to the extinguishing of the back light
and the illumination of both left and right lever lights.
The subject’s task is now to press the same lever that was illuminated in 
the first part of the trial. Correct responses are rewarded with either a) three 
sucrose pellets accompanied by illumination of the feeder light and a 1 sec 
train of 8 clicks/second from the clicker (the “large” outcome) or b) three 
0.5 sec flashes of the feeder light, followed by a single pellet (the “small” 
outcome). For subjects in the DO group (n=8), each stimulus-response 
sequence was consistently followed by a specific outcome (e.g. left-left-
small & right-right-large or left-left-large & right-right-small). For subjects 
in the NDO group (n=8), the outcome was randomly determined. Incorrect 
responses lead to a repeating of the trial; three incorrect responses in a row 
leads to a repeating of the trial, but with only the correct lever illuminated 
at the end of the trial (a forced choice procedure). Only the initial choice on 
each trial is included in overall calculations of accuracy. 
Once subjects learned this task to criterion (3 consecutive days at 85% 
accuracy or above), they were switched to a delayed version of the task, 
where the delay period between the illuminating of the back wall light and 
the time when the trial could be advanced was set to 1, 5,10, or 20 seconds 
on any given trial. After meeting criterion on this task (3 straight days of 
85% or above at 1-second delay and 70% or above at 5-sec delay), subjects 
began drug testing.
Order of drug/control administration was counterbalanced across subjects. 
Subjects were first administered an intraperitoneal injection of scopolamine 
dissolved in saline, at a dose of 0.6 mg/kg, 0.3 m/kg, or saline alone, 30 
minutes before testing in the delayed-version of the task. After an 
approximately 48-hour interval, the second treatment was administered; 
after another 48 hours, the 3rd. Order of treatments was varied according to 
a Latin-square design.
Results and Discussion
Figures 3A and 3B shows accuracy on testing days as a function of group, delay, and 
drug condition, for DO and NDO groups respectively. A mixed-design ANOVA 
showed a significant effect of group, F(1,14)=4.938, p=.043, a significant effect of 
delay, F(3,42)=47.264, p<.001, a significant effect of drug dose, , F(2,28)=21.223, 
p<.001, a significant delay x group interaction, F(3, 42)=6.051, p=.002, a 
nonsignificant dose x group interaction, F(2,28)=.62, p=.545, a nonsignificant dose x 
delay interaction, F(6,84)=1.327, p=.254, and a significant group x delay x dose 
interaction, F(6,84)= 2.348, p=.038. * indicates individual dose that is significantly 
different from saline (p<.05). using Fisher's LSD.
The results of our study suggest that both prospective and retrospective memory are 
mediated by acetylcholine. Previous research by Savage (2008) suggested that 
performance under DO was less affected by scopolamine administration than NDO 
performance; our results stand in contrast to those findings, as scopolamine 
administration reduced accuracy in both groups and arguably reduced it more in the 
DO than NDO group (although this may be simply be because performance under 
DO was higher to begin with.)It is possible that some differences between their 
training procedure and our own are responsible for the difference (e.g. large vs. small 
food instead of food vs. sucrose for outcomes). Moreover, the two doses explored 
here were comparatively large; it is possible that smaller doses could yield a different 
effect for DO and NDO groups. However, it is clear that performance under both 
tasks is dependent on acetylcholine activity. Future studies from our labs will explore 
the effect of a wider range of scopolamine doses, as well as other kinds of amnestic 
drugs, on these two different forms of memory. 
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